Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus 05 March
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update 25 February
Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2025 Financial Results and Host Conference Call on February 25, 2026 18 February
